Trials / Completed
CompletedNCT03177512
LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men
LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing and Pre-exposure Prophylaxis (PrEP) for Young Men Who Have Sex With Men
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Public Health Foundation Enterprises, Inc. · Academic / Other
- Sex
- Male
- Age
- 15 Years – 24 Years
- Healthy volunteers
- Accepted
Summary
This study is testing the acceptability and feasibility of a highly interactive mobile application (app) to promote HIV/sexually transmitted infection (STI) testing and uptake of pre-exposure prophylaxis (PrEP) among young men who have sex with men (YMSM).
Detailed description
Using the Information-Motivation-Behavior Skills (IMB) model, we have developed LYNX, a highly interactive mobile app to promote accurate risk perception and increase HIV/STI testing and linkage to PrEP among young men who have sex with men (YMSM). Key components of the app include Sex Pro (a personalized HIV risk score), a sex diary to facilitate accurate data collection; HIV/STI testing information and reminders; access to home HIV/STI testing options; a geospatial-based locator of HIV/STI testing sites and PrEP clinics; PrEP information and videos; and online PrEP navigation. This study is part of the iTech NIH U19, which has an overall goal to develop innovative technology-focused interventions addressing the HIV prevention and care continuum for youth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | LYNX Mobile App | Access to the LYNX mobile app which includes the Sex Pro score tool, PrEP videos, HIV/STI testing reminders and geo-location features. |
Timeline
- Start date
- 2018-10-25
- Primary completion
- 2019-11-18
- Completion
- 2019-11-18
- First posted
- 2017-06-06
- Last updated
- 2021-05-11
- Results posted
- 2021-05-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03177512. Inclusion in this directory is not an endorsement.